Perrigo Ordinary Shares reported $337.8M in Gross Profit on Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abbott ABT:US $ 6908M 160M
Abbvie ABBV:US $ 9517M 1089M
Bayer BAYN:GR 7.43B 1.54B
Bristol Myers Squibb BMY:US $ 9177M 452M
Catalent CTLT:US $ 423M 18M
Coherus Biosciences CHRS:US $ 50.74M 10.52M
Corcept Therapeutics CORT:US $ 97.47M 2.61M
Dr.Reddys Laboratories DRRD:IN 35.24B 2.36B
Eli Lilly And LLY:US $ 5737.9M 211.8M
Endo International Ordinary Shares ENDP:US $ 472.5M 2.65M
Horizon Pharma HZNP:US $ 670.18M 102.77M
JAZZ PHA JAZZ:US $ 698.44M 62.14M
Johnson & Johnson JNJ:US $ 15828M 1021M
Lannett LCI:US $ 3.08M 2.63M
Merk MRK:US $ 10567M 873M
Pacira Pharmaceuticals PCRX:US $ 121.92M 1.73M
Perrigo Ordinary Shares PRGO:US $ 337.8M 24.6M
Pfizer PFE:US $ 15651M 1516M
Phibro Animal Health PAHC:US $ 71.63M 0.95M
Prestige Brands PBH:US $ 148.86M 6.2M
Supernus Pharmaceuticals SUPN:US $ 142.06M 11.68M
Teva Pharmaceutical TEVA:IT 2.12B 227M
Xeris Pharmaceuticals Inc XERS:US $ 15.8M 740K
Zoetis ZTS:US $ 1371M 37M